Circa 2020

---

Regular and frequent blood glucose monitoring is vital in managing diabetes treatment plans and preventing severe complications. Because current invasive techniques impede patient compliance and are not infection-free, many noninvasive methods have been proposed. Among them, optical methods have drawn much attention for their rich optical contrast, but their resolution is degraded in deep tissue. Here, we present an ultrasound-modulated optical sensing (UOS) technique to noninvasively monitor glucose that uses an infrared laser (1645 nm) and a single-element focused ultrasound transducer. Focused ultrasound waves can acoustically localize diffused photons in scattering media, and thus optical contrast can be represented with much enhanced spatial resolution.

Non-invasive, early detection of invasive cancers — dr. patrizia paterlini-brechot, founder, rarecells diagnostics, ISET technology.

---

Dr. Patrizia Paterlini-Bréchot is a tenured Professor of Cell and Molecular Biology and Oncology at Paris Descartes University and head of a research team at the French National Institute of Health and Medical Research (INSERM).

Dr. Paterlini-Bréchot studied medicine at the University of Modena and Reggio Emilia, where she specialized in hematology and oncology. In 1988 she turned her focus on research in cell and molecular biology and published over 80 research articles and reviews in national and international scientific journals.

The work of Dr. Paterlini-Bréchot led to the discovery of the ISET test (Isolation by SizE of Tumor cells) permitting the isolation and characterization of circulating tumor cells (CTCs), a type of cell that has shed into the vasculature from a primary tumor, is carried around the body in the blood circulation, and can extravasate and become seeds for the subsequent growth of additional tumors (metastases) in distant organs, a mechanism that is responsible for the vast majority of cancer-related deaths.

The ISET test also has interesting applications for the isolation of fetal cells in a mother’s body for potential use in prenatal diagnoses.

ILTV spoke with the co-founder and CEO of Spacepharma Yossi Yamin to discuss the new technology, and its implications for the scientific community.

An antioxidant found in green tea may increase levels of p53, a natural anti-cancer protein, known as the “guardian of the genome” for its ability to repair DNA damage or destroy cancerous cells.

British scientists are developing ‘universal Covid jab’ that would effectively beat all variants of the virus in as little as a YEAR.

---

Nottingham University researchers are working with Oxford-based cancer vaccine firm Scancell (pictured, its chief medical officer) to create the universal vaccine.

According to ‘The Daily Telegraph’, the invisible coating on facemasks attacks the virus by rapturing its outer layer, effectively eliminating all new mutant variants, including the UK’s so-called Kent variant and the South African variant.